EUVIMEDEUVIMED entdecken
Crossref

Fibroblast growth factor 23–secreting pancreaticobiliary malignancy

Valerie Barta, Neel Lalkiya, Huy Phan, Ilene Miller, Mala Sachdeva

Journal of Onco-Nephrology · 2018

DOI: 10.1177/2399369318776177 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Onco-Nephrology, 2018. Verfasst von Valerie Barta und 4 weiteren Autor:innen. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 14 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Malignancy-related tumor-induced osteomalacia is a rare but important entity. We report the first case of oncogenic renal phosphate wasting in the setting of a pancreaticobiliary malignancy. Our patient presented with refractory hypophosphatemia. Workup revealed high fibroblast growth factor 23 levels as well as a new pancreaticobiliary mass. All other causes of hypophosphatemia were ruled out. With tumor-induced osteomalacia, an accurate diagnosis and location of the offending tumor is essential for appropriate management and treatment.

Zitieren

APA

Barta, V., Lalkiya, N., Phan, H., Miller, I., & Sachdeva, M. (2018). Fibroblast growth factor 23–secreting pancreaticobiliary malignancy. Journal of Onco-Nephrology. https://doi.org/10.1177/2399369318776177

Vancouver

Barta V, Lalkiya N, Phan H, Miller I, Sachdeva M. Fibroblast growth factor 23–secreting pancreaticobiliary malignancy. Journal of Onco-Nephrology. 2018. doi:10.1177/2399369318776177

BibTeX
@article{Barta2018,
  author = {Barta, Valerie and Lalkiya, Neel and Phan, Huy and Miller, Ilene and Sachdeva, Mala},
  title = {Fibroblast growth factor 23–secreting pancreaticobiliary malignancy},
  journal = {Journal of Onco-Nephrology},
  year = {2018},
  doi = {10.1177/2399369318776177}
}
Kostenlos starten →